| Literature DB >> 35262498 |
Hannah Beks1, Olivia King2, Renee Clapham3,4, Laura Alston1,5,6, Kristen Glenister7,8, Carol McKinstry9, Claire Quilliam7, Ian Wellwood10, Catherine Williams2, Anna Wong Shee1,4.
Abstract
BACKGROUND: The COVID-19 pandemic has required widespread and rapid adoption of information and communications technology (ICT) platforms by health professionals. Transitioning health programs from face-to-face to remote delivery using ICT platforms has introduced new challenges.Entities:
Keywords: community health services; delivery of health care; information and communications technology; mobile phone; pandemics; telemedicine
Mesh:
Year: 2022 PMID: 35262498 PMCID: PMC8943572 DOI: 10.2196/26515
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Inclusion and exclusion criteria.
|
| Inclusion criteria | Exclusion criteria |
| Population | Health programs delivered for infants, children, young people, and adults, including those delivered for consumers, carers, and family or friends of consumers | No exclusions |
| Concept | Health programs (interventions, models of health care, and services, including, but not limited to, health education, self-management, health promotion and rehabilitation for secondary prevention of disease) delivered by health professionals (including psychologists, speech therapists, speech pathologists, occupational therapists, physiotherapists, physical therapists, podiatrists, exercise physiologists, dietitians, social workers, audiologists, nurses, and doctors) addressing health conditions including, but not limited to, chronic disease (eg, cardiovascular disease, respiratory disease, diabetes, renal disease, cancer, and mental illness) or risk factors for developing chronic disease including, but not limited to, obesity, physical inactivity, poor health literacy, and alcohol misuse using information and communications technology (eg, mobile health, eHealth, telehealth, web-based interventions, and digital health) | Infectious disease screening and surveillance programs, antenatal and postnatal programs, with the exception of gestational diabetes mellitus and postoperative rehabilitation programs |
| Context | Health programs implemented in the community health context in high-income countries (according to the Organization for Economic Co-operation and Development criteria), including primary care clinics and hospital outpatient clinics | Programs delivered in low- and middle-income countries |
Figure 1PRISMA (Preferred Reporting Item for Systematic Reviews and Meta-Analyses) flow diagram. ICT: information and communications technology.
Most frequently reported primary outcome measures in included RCTsa.
| Study | Reported effect and results | |
|
| ||
|
| Baron et al [ | Neutral: Program did not achieve a clinically significant reduction in HbA1c. |
|
| Blackberry et al [ | Neutral: At 18-months follow-up, the effect on HbA1c did not differ between the intervention and control (mean difference 0.2, 95%CI −0.2 to 0.2; |
|
| Buysse et al [ | Positive: Both groups received tele-education at different time points (delayed access [control] and immediate access [study group]) and demonstrated an overall significant impact of tele-education on HbA1c reduction (−0.5% control and −0.4% study group, respectively). |
|
| Carter et al [ | Positive: Patients enrolled in intervention were 4.58 times more likely to achieve an HbA1c target <7%. |
|
| Charpentier et al [ | Positive: At 6 months, mean HbA1c was lower in the intervention group than in the control group (8.41 vs 9.10, respectively). |
|
| Davis et al [ | Positive: A significant reduction in HbA1c was found in the intervention group, compared with usual care (9.4 to 8.2 in the intervention group, compared with 8.8 to 8.6 in usual care). |
|
| Fountoulakis et al [ | Positive: Significant reduction in HbA1c in the intervention group at 3 and 6 months, when compared with that in the control group. |
|
| Greenwood et al [ | Positive: The intervention group had a statistically significant difference of 0.41 percentage points at 6 months when compared with the control group. |
|
| Klingeman et al [ | Positive: Average HbA1c reduced by 1.7% in the intervention group, compared with 0.3% in the control group. |
|
| Sood et al [ | Neutral: No statistically significant differences between the intervention and control groups at 18 months. |
|
| Varney et al [ | Positive: The intervention group experienced a greater mean change in adjusted HbA1c than the controls between baseline and 12 months; however, this was not sustained. |
|
| Wakefield et al [ | Neutral: Participants in the intervention group experienced decreased HbA1c during the 6-month intervention period when compared with the control group; however, 6 months after the intervention was withdrawn, the intervention groups were comparable with the control group. |
|
| Weinstock et al [ | Positive: Intervention was associated with improved HbA1c over 5 years, when compared with control. |
|
| Wild et al [ | Positive: Clinically and statistically significant improvements were observed in the intervention group at 9 months, when compared with the control group. |
|
| ||
|
| Antoniades et al [ | Neutral: No significant difference between the intervention and control groups at 12 months. |
|
| Blumenthal et al [ | Neutral: No significant difference between the intervention and control groups up to 4.4 years follow-up |
|
| Fairbrother et al [ | Neutral: No significant difference between the intervention and control groups at 12 months. |
|
| Pinnock et al [ | Neutral: No significant difference between the intervention and control groups at 12 months. |
|
| Kessler et al [ | Neutral: No significant difference between the intervention and control groups at 12 months. |
|
| Tabak et al [ | Neutral: No significant difference between the intervention and control groups at 2 months. |
|
| ||
|
| Lear et al [ | Positive: Intervention group participants who received support from a health professional through an internet-based platform had a greater increase in maximal time on the treadmill by 45.7 seconds (95% CI 1.04-90.48) compared with the usual care group over the 16 months ( |
|
| Furber et al [ | Positive: After the 6-week intervention, improvements in total PA time, total PA sessions, walking time, and walking sessions were all significantly greater in the intervention group who received telephone support than in the control who received 2 education pamphlets and no support via telephone. |
|
| Hawkes et al [ | Neutral: No significant difference between the PA of participants in the intervention and control groups at 6 months follow-up. |
|
| Hwang et al [ | Neutral: No difference was found between the PA of participants receiving the telerehabilitation intervention when compared with the control group who received center-based care, and it was less costly than center-based heart failure rehabilitation. |
|
| Nolan et al [ | Positive: More telehealth participants than control participants reported adherence to exercise and diet after treatment at a 6-month follow-up. |
|
| ||
|
| Ferrara et al [ | Positive: Compared with those receiving usual care, women in the lifestyle intervention had reduced weekly rate of gestational weight gain (mean 0.26 vs 0.32 kg/week). |
|
| Padwal et al [ | Neutral: Face to-face or web-based delivery of intensive self-management program was no more effective than the once off provision of educational materials and were more costly. |
|
| Weinstock et al [ | Positive: Mean percent weight loss at 2-year follow-up was higher for the conference call group than for the individual call group (−5.6% compared with −1.8%). |
aRCT: randomized controlled trial.
bHbA1c: glycated hemoglobin A1c.
cCOPD: chronic obstructive pulmonary disease.
dPA: physical activity.